Gilead Sciences Trodelvy gets European Commission nod for pre-treated HR+/HER2- metastatic breast cancer Ruchika Sharma28 July 2023 4:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that the European Commission (EC) approved Trodelvy (sacituzumab govitecan) as a monotherapy for...
Gilead to discontinue Phase 3 ENHANCE study of Magrolimab plus Azacitidine in higher-risk MDS Ruchika Sharma24 July 2023 4:45 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Phase 3 ENHANCE study in higher-risk myelodysplastic syndromes (MDS) has been...
Gilead partners with CHAI, Penta to improve treatment, adherence rates among children with HIV in low, middle income countries Ruchika Sharma16 July 2023 10:00 AM ISTFoster City: Gilead Sciences, Inc. has announced two public-private partnerships. The first will accelerate the development of an investigational...
Gilead Sciences gets USFDA nod for Veklury for COVID treatment in patients with severe renal impairment, including those on dialysis Ruchika Sharma15 July 2023 3:30 PM ISTThe updated prescribing information for Veklury does not require dose adjustments for renally-impaired patients and removes the requirement for eGFR...
Kite announces completion of marketing authorization transfer for Yescarta CAR T-cell therapy in Japan Ruchika Sharma25 Jun 2023 2:30 PM ISTSanta Monica: Kite Pharma, Inc., a Gilead Company, has announced that the Marketing Authorization in Japan for Yescarta (axicabtagene...
Gilead Sciences gets CHMP positive opinion for Trodelvy in pre-treated HR+/HER2- metastatic breast cancer Ruchika Sharma24 Jun 2023 4:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
EMA panel grants positive opinion for Remdesivir use in COVID patients with severe renal impairment, including those on dialysis: Gilead Sciences Ruchika Sharma28 May 2023 12:00 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
Gilead Sciences, Arcus Biosciences expand partnership to include research programs in inflammation Ruchika Sharma16 May 2023 10:30 AM ISTFoster City: Gilead Sciences, Inc. and Arcus Biosciences, Inc. have announced that the companies have expanded the previously announced research...
Gilead Sciences acquires all outstanding shares of XinThera Ruchika Sharma13 May 2023 10:00 AM ISTFoster City: Gilead Sciences, Inc. has announced the acquisition of all outstanding shares of XinThera, a privately held biotech company in San...
Gilead Sciences gets EMA panel postive opinion recommending full marketing nod of Hepcludex for HDV Ruchika Sharma5 May 2023 1:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
Gilead Sciences, US square off in billion-dollar HIV drug patent trial Ruchika Sharma2 May 2023 3:46 PM ISTThe USFDA approved Gilead's Truvada for HIV prevention in 2012 and approved its related drug Descovy for the same purpose in 2019.
Gilead Sciences exercises option to license Nurix's investigational targeted protein degrader molecule NX-0479 Ruchika Sharma21 March 2023 5:22 PM ISTFoster City: Gilead Sciences, Inc. and Nurix Therapeutics, Inc., a clinical-stage biopharmaceutical company developing targeted protein...
